Cytomegalovirus (CMV) antibody

Catalog No. ABIN3026154

Product Details

Target: Cytomegalovirus (CMV)

Reactivity: Cytomegalovirus (CMV)

Host: Mouse

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Immunofluorescence (IF), ELISA, Immunocytochemistry (ICC)

Purification: Protein G purified CMV antibody

Clone: CMV100

Isotype: IgG1 kappa

Application Details

Application Notes: The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CMV antibody to be titered up or down for optimal performance.\. ELISA: order BSA-free CMV antibody format for coating,Immunocytochemistry (Acetone or paraformaldehyde fixed) 0.5-1 μg/mL for 30 min,IF: 0.5-1 μg/mL

Restrictions: For Research Use only

Handling

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store the CMV antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).

Target Details

Target: Cytomegalovirus (CMV)

Alternative Name: CMV Cytomegalovirus (CMV Products)

Synonyms: CMVFR antibody, transmembrane anterior posterior transformation 1 antibody, TAPT1 antibody

Target Type: Virus

Background: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.